Nakano, T, et al. (2019) Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence. Am. J. Transplant.. 2019 Jun 4;. PM ID: 31162867
Home | Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence
System Biosciences, LLC
2438 Embarcadero Way
Palo Alto, CA 94303
Toll free: (888) 266-5066
Direct: (650) 968-2200
Fax: (650) 968-2277
© 2018 System Biosciences, LLC. All Rights Reserved. TERMS AND CONDITIONS OF SALE | PRIVACY STATEMENT
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
System Biosciences (SBI) appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. Based on the nature of our business and the products and services we provide, System Biosciences will remain open during the COVID-19 pandemic to support COVID-19 and other essential biomedical research. Many of our employees are working remotely, while our essential on-site employees are working a staggered schedule and following social distancing guidelines.
We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of SBI products and services. Currently, and as we abide by local shelter in place orders, we are fully operational and do not anticipate any material supply disruptions for our products. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.